CareDx Appoints John W. Hanna as its New President and Chief Executive OfficerBusiness Wire • 04/16/24
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation MeetingBusiness Wire • 04/09/24
CareDx (CDNA) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/29/24
CareDx to Participate in the Raymond James & Associates' 45th Annual Institutional Investors ConferenceBusiness Wire • 02/27/24
Unlocking Q4 Potential of CareDx (CDNA): Exploring Wall Street Estimates for Key MetricsZacks Investment Research • 02/26/24
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem MeetingsBusiness Wire • 02/21/24
CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter SymposiumBusiness Wire • 01/11/24
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023Business Wire • 01/09/24
CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication AdherenceBusiness Wire • 12/19/23
How Much Upside is Left in CareDx (CDNA)? Wall Street Analysts Think 26.72%Zacks Investment Research • 12/08/23
Can CareDx (CDNA) Climb 29.79% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 11/22/23
CareDx (CDNA) Surges 16.6%: Is This an Indication of Further Gains?Zacks Investment Research • 11/06/23
CareDx Presents New Data at the American Society for Histocompatibility and Immunogenetics Annual MeetingBusiness Wire • 10/17/23
CareDx Issues Statement on Supreme Court Decision Regarding Stanford-Licensed PatentsBusiness Wire • 10/03/23